TOLERATING A DEGREE OF SUBRETINAL FLUID IN THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) WITH RANIBIZUMAB USING A TREAT AND EXTEND REGIMEN: 24 MONTH RESULTS FROM THE PHASE IV, RANDOMISED, SINGLE-MASKED, MULTI-CENTRE FLUID STUDY

Robyn A. M. Guymer, Caroline Markey, Ian McAllister, Mark Gillies, Alex Hunyor, Jennifer Arnold

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Article numberP0401
Pages (from-to)36-36
Number of pages1
JournalClinical and Experimental Ophthalmology
Volume46
Publication statusPublished - Nov 2018

Cite this